Current status and future prospects of human gene therapy.
Gene therapy is defined as the treatment of diseases by the transfer of genes into patients. Clinical trials of gene therapy became feasible as a result of the development of retroviral mediated gene transfer techniques. The first trial was begun in September 1990 at the National Institutes of Health when a four year old girl was treated for adenosine deaminase deficiency. Currently, more than 500 patients are being treated by this innovative therapeutic strategy. In the present review article, the basic concepts and present status of human gene therapy are summarized.
Shimada
T
T
Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
D000243:Adenosine Deaminase / Q000172:deficiency; D002675:Child, Preschool; D005260:Female; D005544:Forecasting; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D012190:Retroviridae / Q000235:genetics
D000243:Adenosine Deaminase